Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | EPN3 |
| Upstream (Parents) |
|---|
| (<<) ACTG1 → EPN3 |
| (<<) BLNK → EPN3 |
| (<<) CSNK1D → EPN3 |
| (<<) CXCL2 → EPN3 |
| (<<) GOT1 → EPN3 |
| (<<) ITPR3 → EPN3 |
| (<<) LGALS3 → EPN3 |
| (<<) NNMT → EPN3 |
| (<<) PABPC3 → EPN3 |
| (<<) S100P → EPN3 |
| (<<) TAGLN2 → EPN3 |
| (<<) TK1 → EPN3 |
| (<<) YWHAZ → EPN3 |
| Downstream (Children) |
|---|
| EPN3 → CDCP1 (>>) |
| EPN3 → CKB (>>) |
| EPN3 → FUT4 (>>) |
| EPN3 → FZD6 (>>) |
| EPN3 → LRP8 (>>) |
| EPN3 → MAN2A2 (>>) |
| EPN3 → NEDD4 (>>) |
| EPN3 → PAK6 (>>) |
| EPN3 → PLEKHF1 (>>) |
| EPN3 → PRKX (>>) |
| EPN3 → RPS6KA1 (>>) |
| EPN3 → SQLE (>>) |
| EPN3 → STYK1 (>>) |
